U.S. Markets open in 2 hrs 58 mins

Allergan CEO on Innovation and Blockbuster Biopharmaceuticals

Nov.11 -- Brent Saunders, Allergan Chairman & chief executive officer discusses striking a balance between blockbuster therapies and steady growth. He speaks with Bloomberg's Caroline Hyde on 'Bloomberg Markets.'